ClinVar Miner

Submissions for variant NM_000132.3(F8):c.766T>A (p.Tyr256Asn) (rs1569559955)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000756117 SCV000883836 pathogenic not provided 2018-06-27 criteria provided, single submitter clinical testing The F8 c.766T>A; p.Tyr256Asn variant has been described in the literature and observed at ARUP in individuals with mild hemophilia A (Guillet 2006). It is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. The tyrosine at codon 256 is highly conserved, and computational algorithms (PolyPhen-2, SIFT) predict that this variant is deleterious. Additionally, several nearby variants have been reported in individuals with hemophilia A and are considered pathogenic (see link to F8 database and references therein). Based on available information, this variant is considered pathogenic. References: F8 database: http://www.factorviii-db.org/ Guillet B et al. Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institution. Hum Mutat. 2006 Jul;27(7):676-85.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.